🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares induction and consolidation therapy with fluda...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2025-12-12
Trial ID
NCT07228273
A randomized，multicenter, open-label Phase III, clinical study is conducted...
Status
Recruiting
Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Start Date
2023-03-03
Trial ID
NCT05586074
Treatments Being Tested
This is a multicenter, randomized, open-label, pragmatic low intervention c...
Status
Recruiting
Location
University Hospital Brno
Start Date
2025-02-27
Trial ID
NCT06713837
Treatments Being Tested
\- To determine the feasibility of fludarabine and cytarabine as continuous...
Status
Unknown
Location
Asan Medical Center
Start Date
2004-12
Trial ID
NCT00559221
Treatments Being Tested
This is a randomized, multi-center, double-blind, placebo-controlled study ...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2018-08-16
Trial ID
NCT03250338
Treatments Being Tested
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Completed
Location
Site US10011
Start Date
2015-10-20
Trial ID
NCT02421939
The investigators propose a randomized phase 2 study evaluating 90Y-epratuz...
Status
Withdrawn
Location
CHU de Clermont-Ferrand
Start Date
TBD
Trial ID
NCT02844530
Treatments Being Tested
The AML18 Trial will evaluate several relevant therapeutic questions in Acu...
Status
Unknown
Location
Aalborg University Hospital
Start Date
2014-10-30
Trial ID
NCT02272478
This protocol corresponds to a multicenter, open-label, non-randomized, pha...
Status
Completed
Location
Hospital Germans Tries i Pujol, Badalona
Start Date
2018-07-17
Trial ID
NCT03661515
Treatments Being Tested
This open-label, randomized, parallel group phase II study will investigate...
Status
Withdrawn
Location
University of Florida
Start Date
2019-05
Trial ID
NCT03446638